Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Roby Joyce, M.D.

bioAffinity Technologies, Inc. reported in an 8-K filed September 20, 2023 that Roby Joyce, M.D. was appointed Laboratory Director and Medical Director of Precision Pathology Laboratory Services, LLC, effective September 18, 2023.

“Executive shall serve as the Laboratory Director and Medical Director of Precision Pathology Laboratory Services, LLC, a Texas limited liability company ("PPLS"), a subsidiary of the Company.”
bioAffinity Technologies, Inc. Form 8-K, filed September 20, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at bioAffinity Technologies, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.